Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.72 GBX | 0.00% | -8.21% | -25.47% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 01 | HSS Hire annual profit falls amid investment spending; CFO to depart | AN |
Sales 2024 * | 347M 442M | Sales 2025 * | 360M 458M | Capitalization | 61.47M 78.2M |
---|---|---|---|---|---|
Net income 2024 * | 6M 7.63M | Net income 2025 * | 7M 8.9M | EV / Sales 2024 * | 0.45 x |
Net Debt 2024 * | 94.93M 121M | Net Debt 2025 * | 99.46M 127M | EV / Sales 2025 * | 0.45 x |
P/E ratio 2024 * |
9.91
x | P/E ratio 2025 * |
8.73
x | Employees | 2,000 |
Yield 2024 * |
6.62% | Yield 2025 * |
6.81% | Free-Float | 25.3% |
1 week | -8.21% | ||
Current month | -8.21% | ||
1 month | +0.93% | ||
3 months | +0.81% | ||
6 months | -15.13% | ||
Current year | -25.47% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Ashmore
CEO | Chief Executive Officer | 60 | 17-05-31 |
Paul Quested
DFI | Director of Finance/CFO | 54 | 16-04-30 |
Daniel Joll
BRD | Director/Board Member | - | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 15-01-08 | |
Director/Board Member | 71 | 15-01-08 | |
Alan Peterson
CHM | Chairman | 77 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 8.72 | 0.00% | 163,469 |
24-06-06 | 8.72 | -0.91% | 2,964,339 |
24-06-05 | 8.8 | -5.38% | 1,708,014 |
24-06-04 | 9.3 | -1.06% | 500,873 |
24-06-03 | 9.4 | -1.05% | 702,991 |
Delayed Quote London S.E., June 07, 2024 at 11:40 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.47% | 78.22M | |
+12.20% | 42.84B | |
+21.62% | 17.52B | |
-13.93% | 7.28B | |
+9.54% | 5.12B | |
-10.94% | 3.76B | |
-22.51% | 2.93B | |
-11.94% | 2.59B | |
+13.08% | 2.07B | |
-13.93% | 1.63B |
- Stock Market
- Equities
- HSS Stock